Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Leukemia and TYMS[original query] |
---|
Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005 Jun 105 (12): 4752-8. Rocha Jose Claudio C, Cheng Cheng, Liu Wei, Kishi Shinji, Das Soma, Cook Edwin H, Sandlund John T, Rubnitz Jeffrey, Ribeiro Raul, Campana Dario, Pui Ching-Hon, Evans William E, Relling Mary |
Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Dec 14 (12): 2999-3003. Lightfoot Tracy J, Skibola Christine F, Willett Eleanor V, Skibola Danica R, Allan James M, Coppede Fabio, Adamson Peter J, Morgan Gareth J, Roman Eve, Smith Martyn |
Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies. Leukemia research 2009 Jan 33 (1): 82-7. Kim Hee Nam, Kim Yeo-Kyeoung, Lee Il-Kwon, Yang Deok-Hwan, Lee Je-Jung, Shin Min-Ho, Park Kyeong-Soo, Choi Jin-Su, Park Moo Rim, Jo Deog Yeon, Won Jong Ho, Kwak Jae-Yong, Kim Hyeoung-Jo |
A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2008 May 111 (9): 4496-9. French Deborah, Hamilton Leo H, Mattano Leonard A, Sather Harland N, Devidas Meenakshi, Nachman James B, Relling Mary V, |
Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leukemia research 2010 Mar 34 (3): 276-83. Yeoh Allen Eng-Juh, Lu Yi, Chan Jason Yong-Sheng, Chan Yiong Huak, Ariffin Hany, Kham Shirley Kow-Yin, Quah Thuan Cho |
Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia. Cancer causes & control : CCC 2011 Sep 22 (9): 1243-58. Metayer Catherine, Scélo Ghislaine, Chokkalingam Anand P, Barcellos Lisa F, Aldrich Melinda C, Chang Jeffrey S, Guha Neela, Urayama Kevin Y, Hansen Helen M, Block Gladys, Kiley Vincent, Wiencke John K, Wiemels Joseph L, Buffler Patricia |
Polymorphisms in folate-related genes: impact on risk of adult acute lymphoblastic leukemia rather than pediatric in Han Chinese. Leukemia & lymphoma 2011 Sep 52 (9): 1770-6. Yang Lin, Liu Liang, Wang Jianxiang, Qiu Lugui, Mi Yingchang, Ma Xiaotang, Xiao Zhiji |
Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leukemia & lymphoma 2011 Jun 52 (6): 1118-26. Canalle Renata, Silveira Vanessa S, Scrideli Carlos Alberto, Queiroz Rosane G P, Lopes Luiz Fernando, Tone Luiz Gonza |
Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis. Leukemia & lymphoma 2012 Jul 53 (7): 1345-51. Weng Yu, Zhang Jun, Tang Xue, Xie Xinyou, Chen Guang |
Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia. Leukemia & lymphoma 2012 Jun 53 (6): 1096-104. Er?ulj Nina, Kotnik Barbara Faganel, Debeljak Maruša, Jazbec Janez, Dolžan Vi |
A case-parent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer causes & control : CCC 2012 Sep . Lupo PJ, Nousome D, Kamdar KY, Okcu MF, Scheurer ME |
Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL. Pharmacogenomics 2012 Jul 13 (9): 9. Dorababu P, Naushad SM, Linga VG, Gundeti S, Nagesh N, Kutala VK, Reddanna P, Digumarti R |
Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism. PloS one 2012 7 (9): 9. Kim H, Kang HJ, Kim HJ, Jang MK, Kim NH, Oh Y, Han BD, Choi JY, Kim CW, Lee JW, Park KD, Shin HY, Ahn HS |
Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis. PloS one 2013 8 (8): e69843. Lautner-Csorba Orsolya, Gézsi András, Erdélyi Dániel J, Hullám Gábor, Antal Péter, Semsei Ágnes F, Kutszegi Nóra, Kovács Gábor, Falus András, Szalai Csa |
Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome? British journal of clinical pharmacology 2015 Mar 79 (3): 429-40. Hoang Phuong Thu Vu, Ambroise Jérôme, Dekairelle Anne-France, Durant Jean-François, Butoescu Valentina, Chi Vu Luan Dang, Huynh Nghia, Nguyen Tan Binh, Robert Annie, Vermylen Christiane, Gala Jean-L |
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2014 Aug 24 (8): 387-96. Zgheib Nathalie K, Akra-Ismail Maya, Aridi Carol, Mahfouz Rami, Abboud Miguel R, Solh Hassan, Muwakkit Samar |
Association of thymidylate synthase 5'-UTR 28bp tandem repeat and serine hydroxymethyltransfarase C1420T polymorphisms with susceptibility to acute leukemia. Asian Pacific journal of cancer prevention : APJCP 2014 15 (4): 1719-23. Dunna Nageswara Rao, Naushad Shaik Mohammad, Vuree Sugunakar, Anuradha Cingeetham, Sailaja Kagita, Surekha Damineni, Rao Digumarti Raghunadha, Vishnupriya Sat |
The association of folate pathway and DNA repair polymorphisms with susceptibility to childhood acute lymphoblastic leukemia. Gene 2015 Mar . Goricar Katja, Erculj Nina, Faganel Kotnik Barbara, Debeljak Maruša, Hovnik Tinka, Jazbec Janez, Dolžan Vi |
Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2017 Sep 109 480-485. Giletti Andrea, Vital Marcelo, Lorenzo Mariana, Cardozo Patricia, Borelli Gabriel, Gabus Raúl, Martínez Lem, Díaz Lilian, Assar Rodrigo, Rodriguez María Noel, Esperón Patric |
The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2018 Sep . Oosterom Natanja, Berrevoets Marijn, den Hoed Marissa A H, Zolk Oliver, Hoerning Susanne, Pluijm Saskia M F, Pieters Rob, de Jonge Robert, Tissing Wim J E, van den Heuvel-Eibrink Marry M, Heil Sandra |
A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia. Frontiers in oncology 2018 8 541. ElHarouni Dina, Yassin Dina, Ali Nesreen, Gohar Seham, Zaky Iman, Adwan Hassan, Sidhom Im |
Influence of variants in folate metabolism genes on 6-mercaptopurine induced toxicity during treatment for childhood acute lymphocytic leukemia. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 24 (5): 2075-2083. Milosevic Goran, Kotur Nikola, Lazic Jelena, Krstovski Nada, Stankovic Biljana, Zukic Branka, Janic Dragana, Jurisic Vladimir, Pavlovic Sonja, Dokmanovic Lidi |
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment. Genes 2020 Apr 11 (4): . Kotur Nikola, Lazic Jelena, Ristivojevic Bojan, Stankovic Biljana, Gasic Vladimir, Dokmanovic Lidija, Krstovski Nada, Milosevic Goran, Janic Dragana, Zukic Branka, Pavlovic Son |
Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology 2020 Nov . Al-Sheikh Abrar, Yousef Al-Motassem, Alshamaseen Daniah, Farhad Ra |
Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients. Cancer chemotherapy and pharmacology 2022 Mar 89 (3): 393-400. Ramalingam Ravi, Kaur Harpreet, Scott Julius Xavier, Sneha Latha M, Arunkumar Ganeshprasad, Srinivasan Arathi, Paul Solomon F |
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO precision oncology 2023 3 7 e2200580. Larkin Trisha, Kashif Reema, Elsayed Abdelrahman H, Greer Beate, Mangrola Karna, Raffiee Roya, Nguyen Nam, Shastri Vivek, Horn Biljana, Lamba Jatinder |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: